{"id":"https://openalex.org/W2408905364","doi":null,"title":"Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.","display_name":"Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.","alternate_titles":[],"publication_year":1998,"publication_date":"1998-02-01","ids":{"openalex":"https://openalex.org/W2408905364","mag":"2408905364","pmid":"https://pubmed.ncbi.nlm.nih.gov/9541729"},"language":"en","primary_location":{"id":"pmid:9541729","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9541729","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W2408905364"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088767297","display_name":"Philippe Pichat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Pichat","raw_affiliation_strings":["Synth\u00e9labo Recherche, Rueil-Malmaison France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synth\u00e9labo Recherche, Rueil-Malmaison France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103465524","display_name":"Itzchak Angel","orcid":"https://orcid.org/0009-0001-3229-861X","observed_orcids":["https://orcid.org/0009-0001-3229-861X","https://orcid.org/0009-0005-0992-938X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I Angel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060972726","display_name":"Sonia Arbilla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S Arbilla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6911,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.90501266,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"48","issue":"2","first_page":"173","last_page":"178"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.03240000084042549,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mizolastine","display_name":"mizolastine","score":1.0},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.8320000171661377},{"id":"https://openalex.org/keywords/skin-inflammation","display_name":"skin inflammation","score":0.8939999938011169},{"id":"https://openalex.org/keywords/histamine-h1-receptor-antagonists","display_name":"histamine H1 receptor antagonists","score":0.8999999761581421},{"id":"https://openalex.org/keywords/5-lipoxygenase-inhibition","display_name":"5-lipoxygenase inhibition","score":0.9520000219345093},{"id":"https://openalex.org/keywords/lipoxygenase-pathway","display_name":"lipoxygenase pathway","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cyclooxygenase-pathway","display_name":"cyclooxygenase pathway","score":0.8339999914169312},{"id":"https://openalex.org/keywords/carrageenan-induced-inflammation","display_name":"carrageenan-induced inflammation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/loratadine","display_name":"loratadine","score":0.7519999742507935},{"id":"https://openalex.org/keywords/terfenadine","display_name":"terfenadine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mepyramine","display_name":"mepyramine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.8230000138282776},{"id":"https://openalex.org/keywords/allergic-inflammation","display_name":"allergic inflammation","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C2910759140","wikidata":"https://www.wikidata.org/wiki/Q3800087","display_name":"Pyrilamine","level":4,"score":0.8521378040313721},{"id":"https://openalex.org/C10335311","wikidata":"https://www.wikidata.org/wiki/Q309513","display_name":"Histamine H1 receptor","level":4,"score":0.7761074900627136},{"id":"https://openalex.org/C2780734495","wikidata":"https://www.wikidata.org/wiki/Q424049","display_name":"Loratadine","level":2,"score":0.7483262419700623},{"id":"https://openalex.org/C2779303165","wikidata":"https://www.wikidata.org/wiki/Q417909","display_name":"Terfenadine","level":2,"score":0.731523334980011},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.720389187335968},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6315550208091736},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5013370513916016},{"id":"https://openalex.org/C2909530563","wikidata":"https://www.wikidata.org/wiki/Q1328275","display_name":"Histamine H1 Antagonists","level":3,"score":0.4708026647567749},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.469440221786499},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37217801809310913},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3406732380390167},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3121248781681061},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.27421411871910095},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18001076579093933}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002351","descriptor_name":"Carrageenan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003872","descriptor_name":"Dermatitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003872","descriptor_name":"Dermatitis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007052","descriptor_name":"Ibuprofen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016718","descriptor_name":"Arachidonic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9541729","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9541729","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Comparative Study"},{"id":"mag:2408905364","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9541729","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2385068605","https://openalex.org/W2394166845","https://openalex.org/W2364000576","https://openalex.org/W2350206374","https://openalex.org/W2357815124","https://openalex.org/W2356301585","https://openalex.org/W179749338","https://openalex.org/W2509661385","https://openalex.org/W2365700146","https://openalex.org/W1971773128"],"abstract_inverted_index":{"The":[0],"anti-inflammatory":[1,181],"effect":[2,75,182,199],"of":[3,25,61,70,84,96,107,148,153,172,183,209,228,267],"mizolastine":[4,169,184,218,229,252],"(CAS":[5],"108612-45-9,":[6],"SL85.0324-00),":[7],"a":[8,36,55,92,103,197,225],"new":[9],"non-sedative":[10],"histamine":[11,123,189,268],"H1-receptor":[12,124,190],"antagonist,":[13],"was":[14,33,76,109,175,185],"assessed":[15],"in":[16,54,222,256,278],"comparison":[17],"to":[18,48,128,142,187,206,238,274],"loratadine,":[19],"terfenadine":[20,126],"and":[21,38,136],"pyrilamine.":[22],"Intraplantar":[23],"injection":[24],"arachidonic":[26],"acid":[27],"(AA)":[28],"into":[29],"the":[30,58,62,68,81,122,145,166,180,201,215,235,244],"rat":[31],"paw":[32,64],"followed":[34],"by":[35,168,243],"rapid":[37],"sustained":[39],"(>":[40],"or":[41,161,281],"=":[42],"4h)":[43],"inflammatory":[44,146,236,283],"oedema.":[45],"Mizolastine":[46],"(0.1":[47],"10":[49],"mg/":[50],"kg":[51],"p.o.)":[52,90,140],"inhibited":[53],"dose-dependent":[56],"manner":[57],"time":[59,105],"course":[60,106],"AA-induced":[63,173],"inflammation":[65,174,280],"as":[66],"from":[67],"dose":[69,227],"0.1":[71,114],"mg/kg":[72,89,115,130,134,139,164],"p.o.":[73,116],"This":[74,177,211],"maintained":[77],"for":[78,260],"at":[79,87,113,119],"least":[80],"4":[82],"h":[83],"observation":[85],"(-44%":[86],"0.3":[88],"suggesting":[91],"long":[93],"lasting":[94],"action":[95,147,208],"mizolastine.":[97,210],"Although":[98],"with":[99,111,159,264],"higher":[100],"maximal":[101],"effect,":[102],"similar":[104],"response":[108,237],"observed":[110],"dexamethasone":[112],"In":[117],"contrast,":[118],"anti-histamine,":[120],"doses,":[121],"antagonists":[125],"(1":[127],"30":[129],"p.o.),":[131,135,165],"loratadine":[132,162],"(10":[133,138,163],"pyrilamine":[137,160],"failed":[141],"inhibit":[143],"significantly":[144],"AA.":[149],"Moreover,":[150],"under":[151],"conditions":[152],"H1-receptors":[154],"blockade":[155,266],"(e.g.":[156],"when":[157],"co-administered":[158],"inhibition":[167],"(0.3":[170],"mg/kg)":[171,231],"unchanged.":[176],"suggests":[178],"that":[179,196,217,251],"unrelated":[186],"its":[188,265,275],"antagonist":[191],"properties.":[192],"It":[193],"is":[194,212,241,253],"proposed":[195],"primary":[198],"on":[200,214],"lipoxygenase":[202],"pathway":[203],"may":[204,272],"contribute":[205,273],"this":[207,257,270],"based":[213],"observations":[216],"inhibits":[219],"5-lipoxygenase":[220],"activity":[221],"vitro.":[223],"Furthermore,":[224],"high":[226],"(50":[230],"did":[232],"not":[233],"affect":[234],"carrageenin":[239],"which":[240],"mediated":[242],"cyclooxygenase":[245],"pathway.":[246],"Together,":[247],"these":[248],"data":[249],"indicate":[250],"orally":[254],"effective":[255],"animal":[258],"model":[259],"cutaneous":[261],"inflammation.":[262],"Combined":[263],"H1-receptors,":[269],"property":[271],"possible":[276],"use":[277],"allergic":[279],"other":[282],"states.":[284]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2408905364","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
